KRAS and neoplasm: Laklai and colleagues23 previously demonstrated that in the context of mutant Kras, a loss of Tgf-β receptor 2 signaling resulted in elevated Stat3 signaling and tumor progression, while epithelial Stat3 ablation attenuated tumor progression and prolonged survival.